Galderma Receives Filing Acceptances for Nemolizumab in Prurigo Nodularis and Atopic Dermatitis in Four Additional Countries
ZUG, Switzerland--(BUSINESS WIRE)--May 7, 2024--
Source: valdostadailytimes.com
Access Consortium News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Access Consortium. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Access Consortium Today - Breaking & Trending Today
TGA Backs MHRA's Global Recognition for Drugs
Miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Source: miragenews.com
United States, Japan and Australia added to UK fast-track medicines approvals list
The Pharmaceutical Journal from the Royal Pharmaceutical Society
Source: pharmaceutical-journal.com
Veru Inc. (NASDAQ:VERU) Q4 2022 Earnings Call Transcript
Operator: Good morning ladies and gentlemen, and welcome to Veru Inc.'s Investor Conference Call. All participants will be in listen-only mode.
Source: insidermonkey.com
CSL Vifor: Kapruvia approved in Switzerland with additional regulatory decisions expected in H2 2022
Kapruvia (difelikefalin) is the first and only therapy approved through consortium filing for the treatment of chronic kidney disease (CKD)-associated pruritus in hemodialysis patients Therapy recently
Source: finanznachrichten.de